Schizophrenia News and Research

Latest Schizophrenia News and Research

Lenalidomide effective alternative in lupus

The thalidomide derivative, lenalidomide, is a “safe” and effective treatment in refractory cutaneous lupus erythematosus patients, although three-quarters of patients experience clinical relapse after the drug is withdrawn, say Spanish researchers.

11 Dec 2012

Immune dysfunction pinpointed in developmental disorder

Children with neurodevelopmental abnormalities resulting from duplication of the methyl-CpG binding protein 2 gene also have impaired T-helper-cell 1 responses, research shows.

10 Dec 2012

Novel antidepressant targets brain receptors responsible for learning and memory

A first-of-its-kind antidepressant drug discovered by a Northwestern University professor and now tested on adults who have failed other antidepressant therapies has been shown to alleviate symptoms within hours, have good safety and produce positive effects that last for about seven days from a single dose.

7 Dec 2012

Pesticides in tap water may increase food allergy risk

Having a high level of urinary dichlorophenols is associated with the presence of food sensitization and allergies, say researchers.

7 Dec 2012

CRP40 may have pathogenic role in schizophrenia

Gene expression of catecholamine-regulated protein 40 is dysregulated in people with schizophrenia, study findings show.

7 Dec 2012

Study demonstrates how parasites enter the brain to influence its host

Toxoplasma is a common 'cat parasite', and has previously been in the spotlight owing to its observed effect on risk-taking and other human behaviours. To some extent, it has also been associated with mental illness. A study led by researchers from Karolinska Institutet in Sweden now demonstrates for the first time how the parasite enters the brain to influence its host.

7 Dec 2012

Naurex reports positive results from GLYX-13 Phase IIa trial on depression

Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today reported positive results from a Phase IIa clinical trial of its lead antidepressant compound, GLYX-13.

6 Dec 2012

C-reactive protein levels increased in schizophrenia

Patients with schizophrenia have elevated levels of high-sensitivity C-reactive protein compared with mentally healthy individuals, US researchers report.

6 Dec 2012

C-reactive protein levels increased in schizophrenia

Patients with schizophrenia have elevated levels of high sensitivity C-reactive protein compared with mentally healthy individuals, US researchers report.

6 Dec 2012

Depression, anxiety not linked to psychosis transition

Depression and anxiety disorders are common in patients at increased clinical risk for psychosis, but do not appear to influence transition to full-blown psychosis, say UK researchers.

5 Dec 2012

Vitamin D and women’s risk for multiple sclerosis

Women who have high vitamin D levels are at a decreased risk for developing multiple sclerosis, shows research.

5 Dec 2012

Rethinking therapy decisions in autoimmune encephalopathy

Researchers say that diagnosis and management of encephalopathies may need to be rethought, as many patients who test negative for the relevant antibody still benefit from immunotherapy.

4 Dec 2012

Vasculitis and the metabolic syndrome frequently co-exist

The metabolic syndrome is significantly more common in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis than healthy individuals, researchers have found.

3 Dec 2012

Reduced production of myelin may play role in development of mental illness: Study

Reduced production of myelin, a type of protective nerve fiber that is lost in diseases like multiple sclerosis, may also play a role in the development of mental illness, according to researchers at the Graduate School of Biomedical Sciences at Mount Sinai School of Medicine.

1 Dec 2012

Deficiencies in sensory information processing can explain complex symptoms of schizophrenia

Researchers at the University of California, San Diego School of Medicine and the VA San Diego Healthcare System have found that deficiencies in the neural processing of simple auditory tones can evolve into a cascade of dysfunctional information processing across wide swaths of the brain in patients with schizophrenia.

30 Nov 2012

Asthma and nasal congestion common insomnia triggers

Insomnia is a common problem in patients with asthma, suggests research published in Allergy.

30 Nov 2012

Tdap well tolerated in over-65s

Off-label use of tetanus–diptheria–acellular pertussis vaccine in senior patients results in no more adverse events than the tetanus and diphtheria vaccine, a US study shows.

30 Nov 2012

Poor empathy may feature in common psychiatric conditions

Individuals with schizophrenia, bipolar disorder, or depression may be less empathic than individuals without these conditions, according to German study results.

30 Nov 2012

Yale and Mainz University Medical Center to extend collaboration

The University Medical Center at Johannes Gutenberg University Mainz, Germany and the renowned School of Medicine at Yale University, USA have agreed upon a future collaboration. This strategic partnership promises to provide an innovative stimulus for the Research Unit Translational Neurosciences at the Mainz University Medical Center. The resulting regular exchange will benefit both basic research and the training of young researchers.

29 Nov 2012

Reduction in myelin production may also play a role in development of mental illness

29 Nov 2012

Schizophrenia News and Research

Latest Schizophrenia News and Research

Lenalidomide effective alternative in lupus

Immune dysfunction pinpointed in developmental disorder

Novel antidepressant targets brain receptors responsible for learning and memory

Pesticides in tap water may increase food allergy risk

CRP40 may have pathogenic role in schizophrenia

Study demonstrates how parasites enter the brain to influence its host

Naurex reports positive results from GLYX-13 Phase IIa trial on depression

C-reactive protein levels increased in schizophrenia

C-reactive protein levels increased in schizophrenia

Depression, anxiety not linked to psychosis transition

Vitamin D and women’s risk for multiple sclerosis

Rethinking therapy decisions in autoimmune encephalopathy

Vasculitis and the metabolic syndrome frequently co-exist

Reduced production of myelin may play role in development of mental illness: Study

Deficiencies in sensory information processing can explain complex symptoms of schizophrenia

Asthma and nasal congestion common insomnia triggers

Tdap well tolerated in over-65s

Poor empathy may feature in common psychiatric conditions

Yale and Mainz University Medical Center to extend collaboration

Reduction in myelin production may also play a role in development of mental illness

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Schizophrenia News and Research

Latest Schizophrenia News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in